Search Result "inhibitor-oxaliplatin"
Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14 Issue: 7 Year: 2014 Page: 1042-1050
Author(s): Masaki Akiyama,Hiroto Izumi,Ke-Yong Wang,Takahiro Yamaguchi,Akihiro Kuma,Noriaki Kitamura,Yoshikazu Harada,Ryoichi Oya,Koji Yamaguchi,Yoshiko Iwai,Kimitoshi Kohno
OSI-027 Alleviates Oxaliplatin Chemoresistance in Gastric Cancer Cells by Suppressing P-gp Induction
Journal: Current Molecular Medicine
Volume: 21 Issue: 10 Year: 2021 Page: 922-930
Author(s): En Xu,Hao Zhu,Feng Wang,Ji Miao,Shangce Du,Chang Zheng,Xingzhou Wang,Zijian Li,Feng Xu,Xuefeng Xia,Wenxian Guan
Colorectal Cancer Chemotherapy: The Evolution of Treatment and New Approaches
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 1537-1557
Author(s): Rachel M. McQuade,Vanesa Stojanovska,Joel C. Bornstein,Kulmira Nurgali
Monoclonal Antibodies Against Epidermal Growth Factor Receptor in Advanced Colorectal Carcinoma: Clinical Efficacy and Markers of Sensitivity&#
Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 2 Year: 2006 Page: 113-118
Author(s): Enric Carcereny, Joan Maurel
Comparison of Bromhexine and its Active Metabolite - Ambroxol as Potential Analgesics Reducing Oxaliplatin-induced Neuropathic Pain - Pharmacodynamic and Molecular Docking Studies
Journal: Current Drug Metabolism
Volume: 21 Issue: 7 Year: 2020 Page: 548-561
Author(s): Anna FurgaÅa-Wojas,Magdalena Kowalska,Alicja Nowaczyk,Åukasz FijaÅkowski,Kinga SaÅat
Network Perspectives on HDM2 Inhibitor Chemotherapy Combinations
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 6 Year: 2011 Page: 640-652
Author(s): Asfar S. Azmi, Frances W.J. Beck, Fazlul H. Sarkar, Ramzi M. Mohammad
Recent Developments in the Field of Anticancer Platinum Complexes
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 2 Year: 2006 Page: 285-295
Author(s): Markus Galanski
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 10 Year: 2020 Page: 811-817
Author(s): Sven Nilsson,Alexander Stein,Christian Rolfo,Anne L. Kranich,Julia Mann,Konstantinos Papadimitriou,Susann Theile,Stefanie Amberg,Carsten Bokemeyer
Chemoresistance Mechanisms in Colon Cancer: Focus on Conventional Chemotherapy
Journal: Clinical Cancer Drugs
Volume: 8 Issue: 2 Year: 2021 Page: 67-105
Author(s): Mirela SediÄ,Klara MladeniÄ
Colorectal Cancer Therapeutic Approaches: From Classical Drugs to New Nanoparticles
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 7 Year: 2016
Author(s): Giulia Cazzanelli,Tiago Moreira,Suellen Ferro,João Azevedo-Silva,Eugénia Nogueira,Ana Preto
Doi: 10.2174/9781681082516116070004